Ischaemic heart disease - Combined oral contraceptive pill Factor
The combined oral contraceptive pill contains both oestrogen and progestogen.
Oral contraceptives
Last reviewed for CCPS 27 April 2010.
Preliminary questions [33441]
25110 there is some evidence that taking the combined oral contraceptive pill may be a factor in the development of the condition under consideration.
1169 the veteran is a woman.
12789 the veteran has taken oral contraceptives containing oestrogen and progestogen.
33442 the veteran has established the causal connection between using the combined oral contraceptive pill and operational service for ischaemic heart disease.
35821 the veteran used oral contraceptives containing oestrogen and progestogen for at least the 21 days before the clinical onset of the condition under consideration.
33444 the veteran has established the causal connection between using the combined oral contraceptive pill and operational service for the clinical onset of ischaemic heart disease.
or
7334 the clinical onset of the condition under consideration occurred after the end of the veteran's last period of VEA service.
7335 the condition under consideration permanently worsened.
35822 the veteran used oral contraceptives containing oestrogen and progestogen for at least the 21 days before the clinical worsening of the condition under consideration.
33443 the veteran has established the causal connection between using the combined oral contraceptive pill and operational service for the clinical worsening of ischaemic heart disease.
Clinical onset and operational service [33444]
35801 as a causal result of operational service, the veteran used oral contraceptives containing oestrogen and progestogen for at least the 21 days before the clinical onset of the condition under consideration.
or
38902 the veteran used oral contraceptives containing oestrogen and progestogen for at least the 21 days before the clinical onset or the clinical worsening of the condition under consideration for treatment of an illness or injury which is identifiable.
33501 the veteran used oral contraceptives containing oestrogen and progestogen for treatment of the identified illness or injury for at least the 21 days before the clinical onset of the condition under consideration.
12795 the identified illness or injury, for which the veteran was treated with the combined oral contraceptive pill, is causally related to operational service.
Clinical worsening and operational service [33443]
35802 as a causal result of operational service, the veteran used oral contraceptives containing oestrogen and progestogen for at least the 21 days before the clinical worsening of the condition under consideration.
or
38902 the veteran used oral contraceptives containing oestrogen and progestogen for at least the 21 days before the clinical onset or the clinical worsening of the condition under consideration for treatment of an illness or injury which is identifiable.
33502 the veteran used oral contraceptives containing oestrogen and progestogen for treatment of the identified illness or injury for at least the 21 days before the clinical worsening of the condition under consideration.
12795 the identified illness or injury, for which the veteran was treated with the combined oral contraceptive pill, is causally related to operational service.
33503 the clinical onset of the condition under consideration occurred prior to that part of operational service to which the identified illness or injury for which the oral contraceptives containing oestrogen and progestogen were taken is causally related.